Toxicology – Carbamate Insecticides

Core concept

Carbamate insecticides produce an acute cholinergic toxidrome by reversibly inhibiting acetylcholinesterase (AChE).

The classic syndrome is:

Excess acetylcholine → bronchorrhea + bronchospasm + salivation + vomiting/diarrhea + miosis + fasciculations/weakness ± seizures

The immediate life-threatening problem is:

Respiratory failure

from a combination of:

Bronchorrhea/bronchospasm + neuromuscular weakness + CNS respiratory depression

The cornerstone of antidotal treatment is:

Atropine

A major modern distinction from organophosphate poisoning is:

Carbamate-AChE inhibition is reversible and does not “age.”

Therefore, pralidoxime is usually unnecessary in a confirmed isolated carbamate poisoning, although it remains reasonable when the pesticide is unidentified or organophosphate exposure cannot be excluded.

Important Agents

Clinically important carbamate insecticides include:

• Aldicarb
• Carbaryl
• Carbofuran
• Methomyl
• Oxamyl
• Propoxur
• Bendiocarb
• Methiocarb
• Pirimicarb
• Thiodicarb
• Carbosulfan

The older classification into “low-, moderate-, and high-toxicity” groups should not be relied on clinically.

Some carbamates—particularly agents such as aldicarb and carbofuran—can produce severe, rapidly fatal poisoning.

Severity depends on:

• Specific compound
• Concentration
• Formulation
• Dose
• Route
• Coformulants/solvents
• Delay to treatment

Routes of Exposure

Carbamate insecticides can be absorbed by:

• Ingestion
• Skin
• Inhalation
• Eyes/mucous membranes

Occupational poisoning frequently occurs through dermal exposure during:

• Mixing
• Spraying
• Agricultural work
• Contact with recently treated plants

Intentional poisoning is usually oral.

Symptoms can develop rapidly after substantial exposure, sometimes within minutes.

Pathophysiology

Normally:

Acetylcholine → binds receptor → acetylcholinesterase rapidly terminates signaling

Carbamates cause:

Carbamylation of AChE → reversible AChE inhibition → acetylcholine accumulation

Excess acetylcholine stimulates:

1. Muscarinic receptors
2. Nicotinic receptors
3. CNS cholinergic pathways

Carbamates vs Organophosphates

Both cause acute cholinergic poisoning.

But:

Carbamates

Reversible carbamylation of AChE

→ spontaneous hydrolysis/reactivation

→ toxicity often resolves within 24 hours, sometimes 24–48 hours

Organophosphates

Phosphorylation of AChE

→ may undergo aging

→ prolonged toxicity

→ oximes have a stronger mechanistic rationale

This distinction becomes especially important when deciding whether to use pralidoxime.

Clinical Features

The Cholinergic Toxidrome

A traditional mnemonic is:

DUMBELS

• D – Defecation/diarrhea, diaphoresis
• U – Urination
• M – Miosis
• B – Bronchorrhea, bronchospasm, bradycardia
• E – Emesis
• L – Lacrimation
• S – Salivation

However, the most clinically useful way to organize toxicity is by receptor type.

Muscarinic Effects

Pulmonary

The most dangerous muscarinic effects are:

• Bronchorrhea
• Bronchospasm
• Excessive oral secretions

These may produce:

• Wheezing
• Crackles
• Hypoxemia
• Respiratory distress

HEENT

• Miosis
• Blurred vision
• Lacrimation
• Rhinorrhea
• Salivation

Gastrointestinal

• Nausea
• Vomiting
• Abdominal cramping
• Diarrhea
• Increased bowel sounds

Genitourinary

• Urinary urgency
• Urinary incontinence

Dermatologic

• Profuse sweating

Remember that sympathetic sweat glands use acetylcholine.

Cardiovascular

Possible findings include:

• Bradycardia
• Hypotension
• AV conduction abnormalities

Nicotinic Effects

At autonomic ganglia, excess acetylcholine may produce either sympathetic or parasympathetic manifestations.

Therefore, patients may have:

• Tachycardia
• Hypertension
• Mydriasis

despite having a cholinergic pesticide poisoning.

At the neuromuscular junction:

Nicotinic stimulation → fasciculations → weakness → flaccid paralysis

Clinical findings include:

• Muscle twitching
• Fasciculations
• Generalized weakness
• Neck weakness
• Respiratory-muscle weakness
• Paralysis

Mixed autonomic presentations are common, so tachycardia does not exclude carbamate toxicity.

CNS Effects

Possible central manifestations include:

• Anxiety
• Restlessness
• Confusion
• Delirium
• Tremor
• Ataxia
• Seizures
• Depressed consciousness
• Coma

Children may show particularly prominent CNS depression.

Respiratory Failure

This is the major cause of death.

Three mechanisms often coexist:

1. Wet lungs

Bronchorrhea + bronchospasm

2. Weak respiratory muscles

Nicotinic neuromuscular toxicity

3. Impaired respiratory drive

Central cholinergic toxicity

Therefore:

Clearing secretions with atropine does not guarantee that ventilation is adequate.

Atropine does not reverse nicotinic skeletal-muscle paralysis.

Cardiovascular Toxicity

Possible abnormalities include:

• Bradycardia
• Tachycardia
• Hypotension
• Hypertension
• AV block
• Atrial dysrhythmias

Severe poisoning can progress to:

• Cardiovascular collapse
• Asystole

Hypoxia is often an important contributor to cardiac instability.

Pulmonary Edema / Aspiration

Chest abnormalities can arise from:

• Cholinergic bronchorrhea
• Aspiration
• Chemical pneumonitis from pesticide solvents
• Secondary pulmonary edema

Many commercial pesticide formulations contain:

• Hydrocarbons
• Surfactants
• Other solvents

Therefore, the complete product formulation matters.

Toxic Dose

There is no clinically useful single toxic dose for carbamate insecticides.

Toxicity varies greatly between compounds.

A small exposure to a highly potent agent may be more dangerous than a much larger exposure to another carbamate.

Therefore:

Do not use the number of tablets, milliliters, or grams alone to exclude serious toxicity.

Whenever possible identify:

• Active ingredient
• Percentage concentration
• Commercial formulation
• Estimated amount
• Route and time

Diagnosis

Diagnosis is primarily clinical:

Compatible exposure + cholinergic toxidrome

Treatment must not wait for cholinesterase testing.

Cholinesterase Testing

Two commonly measured enzymes are:

RBC acetylcholinesterase

More closely reflects AChE activity at neuronal/neuromuscular sites.

Plasma butyrylcholinesterase

Sometimes called:

• Plasma cholinesterase
• Pseudocholinesterase

It is easier to measure in many laboratories.

Important Carbamate Testing Limitation

The older source presents fixed cholinesterase percentages as though they reliably classify poisoning severity.

That is overly simplistic.

Because carbamate-AChE binding is rapidly reversible:

Cholinesterase activity may recover rapidly after blood is drawn or before testing occurs.

Therefore:

• A normal result does not reliably exclude carbamate poisoning
• Sample handling and processing time matter
• Clinical toxicity is more important than a numerical enzyme level

CDC has specifically noted that cholinesterase testing can be unreliable in carbamate poisoning because the inhibition reverses rapidly.

Practical rule

Draw cholinesterase levels when useful—but do not delay atropine or airway management to obtain them.

Other Laboratory Tests

In moderate/severe poisoning obtain:

• Glucose
• Electrolytes
• Potassium
• Magnesium
• Calcium
• Bicarbonate
• BUN
• Creatinine

Consider:

• Blood gas
• Lactate

when:

• Hypoxemia
• Shock
• Respiratory failure
• Significant acidosis

is present.

ECG

Obtain:

• 12-lead ECG
• Continuous cardiac monitoring

in symptomatic patients.

Monitor for:

• Bradycardia
• Tachyarrhythmia
• AV block
• Ischemic changes
• Dysrhythmia secondary to hypoxia/electrolyte abnormalities

Chest Imaging

Chest radiography is appropriate when there is:

• Hypoxemia
• Persistent respiratory distress
• Suspected aspiration
• Pulmonary edema
• Abnormal lung examination not resolving with atropine

Remember that persistent crackles after adequate atropinization may represent aspiration, rather than continued cholinergic bronchorrhea.

Differential Diagnosis

Organophosphate poisoning

The most important differential.

Initially:

Treat severe undifferentiated cholinesterase-inhibitor poisoning similarly until the compound is identified.

Other toxicologic causes

• Nicotine
• Neostigmine
• Pyridostigmine
• Physostigmine
• Donepezil
• Pilocarpine
• Bethanechol
• Muscarine-containing mushrooms

Medical mimics

Depending on presentation:

• Myasthenic crisis
• Severe asthma
• Pulmonary edema
• Sepsis
• Bradyarrhythmia from another cause

Treatment

1. Protect Healthcare Personnel

This is an important part of the initial management.

A contaminated patient can expose:

• Paramedics
• Nurses
• Physicians
• Family members

especially through:

• Wet clothing
• Skin contamination
• Vomitus
• Diarrhea
• Pesticide solvents

Healthcare-associated pesticide poisoning has occurred after inadequately decontaminated patients were brought into emergency departments.

Use appropriate:

• Gloves
• Protective gown
• Eye protection

and respiratory protection when the formulation or exposure environment warrants it.

2. Decontamination

Clothing

Remove contaminated clothing promptly.

Removing clothing alone can eliminate a large fraction of external chemical contamination. Current CDC chemical-emergency guidance recommends rapid clothing removal and washing after significant contamination.

Place contaminated clothing in appropriate sealed containers/bags.

Skin

Wash exposed skin and hair thoroughly with:

• Water
• Soap and water
• Then rinse

Do not aggressively abrade the skin.

Current carbamate guidance recommends thorough skin washing because continued dermal absorption can occur.

Eyes

Immediately irrigate exposed eyes with:

• Water
• Normal saline

Remove contact lenses.

3. Airway and Ventilation

The priorities are:

Suction → oxygenation → ventilation → atropine

Clear excessive secretions aggressively.

Early endotracheal intubation is appropriate for:

• Inability to manage secretions
• Severe hypoxemia
• Coma
• Severe respiratory-muscle weakness
• Inadequate ventilation

Avoid Succinylcholine

This is an important anesthesia/intubation pearl.

Because cholinesterase activity can be inhibited:

Succinylcholine paralysis may be markedly prolonged.

A nondepolarizing neuromuscular blocker such as:

Rocuronium

is generally preferable when paralysis is required for rapid-sequence intubation.

Atropine

Main antidote

Atropine is the essential antidote for clinically important muscarinic toxicity.

It competitively blocks muscarinic acetylcholine receptors.

It improves:

• Bronchorrhea
• Bronchospasm
• Salivation
• Bradycardia
• Hypotension related to muscarinic excess

It does not directly reverse:

• Fasciculations
• Neuromuscular weakness
• Respiratory-muscle paralysis

Initial Atropine Dose

A contemporary carbamate reference recommends:

Adult

1–3 mg IV initially

Pediatric

0.05 mg/kg IV

with a minimum dose of approximately:

0.1 mg

Rapid Dose Escalation

If response is inadequate:

Double the atropine dose approximately every 5 minutes

For example:

2 mg → 4 mg → 8 mg → 16 mg → 32 mg

until adequate cardiorespiratory atropinization is achieved.

The older strategy of repeatedly administering the same small dose every 5–10 minutes can take too long in a critically poisoned patient.

Atropine Endpoint

This is one of the most important modern updates.

Do not titrate atropine primarily to:

• Dilated pupils
• Complete dry mouth
• A specific heart rate

Instead target:

Drying of dangerous bronchial secretions + relief of bronchospasm + adequate perfusion

Specifically:

• Bronchorrhea markedly reduced
• Chest substantially clearer
• Oxygenation/ventilation improving
• Blood pressure adequate
• Heart rate adequate for perfusion

Tachycardia Is Not a Contraindication

A poisoned patient may already be tachycardic because of:

• Hypoxia
• Nicotinic ganglionic stimulation
• Stress
• Severe respiratory distress

Therefore:

Do not withhold needed atropine solely because the heart rate is high if the lungs remain wet and bronchospastic.

Atropine Infusion

If repeated toxicity occurs after loading:

Begin an infusion at approximately:

10–20% of the total effective loading dose per hour

and titrate according to:

• Bronchial secretions
• Respiratory status
• Perfusion

Because carbamate toxicity is usually relatively short-lived, prolonged atropine infusions are less commonly necessary than after major organophosphate poisoning.

Atropine Toxicity

Over-atropinization may cause:

• Delirium
• Agitation
• Hyperthermia
• Ileus
• Urinary retention
• Marked tachycardia

Treatment must continually balance:

• Recurrent cholinergic toxicity
• against
• Excess atropine

Pralidoxime (2-PAM)

Major modern update

The older textbook states:

“Atropine and pralidoxime are antidotes for carbamate poisoning.”

That is too broad.

Carbamates spontaneously dissociate from AChE and do not undergo aging.

Therefore:

Pralidoxime is generally not required for a confirmed isolated carbamate poisoning.

Carbaryl

Experimental data have raised concern that pralidoxime may actually increase AChE inhibition in carbaryl poisoning.

Therefore:

Avoid routine pralidoxime in known isolated carbaryl poisoning.

When Pralidoxime IS Reasonable

Real-world pesticide exposure is often uncertain.

If a patient has severe cholinergic poisoning and:

• The pesticide is unidentified
• Organophosphate exposure cannot be excluded
• Mixed pesticide exposure is possible

then:

Give pralidoxime while treating as possible organophosphate poisoning.

The harm from missing severe organophosphate toxicity generally outweighs the limited concern about oxime use in most unidentified pesticide cases.

Practical rule

Confirmed pure carbamate → atropine; usually no 2-PAM

Unknown OP vs carbamate → atropine + consider 2-PAM

Gastrointestinal Decontamination

Do Not Induce Vomiting

Do not use ipecac or induce emesis.

A cholinergic patient already has:

• Vomiting
• Excess secretions
• Risk of altered consciousness
• Risk of seizures
• High aspiration risk

Activated Charcoal

Routine charcoal is not necessary for all carbamate ingestions.

After a massive, very recent ingestion, single-dose activated charcoal may be considered when:

• Presentation is approximately within 1 hour
• Airway is intact or protected
• Aspiration risk is acceptable

Evidence for adsorption and clinical benefit is limited, so toxicology/poison-center consultation is appropriate.

Gastric Lavage

Routine gastric lavage is not standard modern therapy.

It may be considered only in highly selected circumstances involving:

• Massive life-threatening ingestion
• Very early presentation
• Protected airway
• Specialist toxicology input

Resuscitation and atropinization take priority.

Seizures

First-line treatment:

Benzodiazepines

Examples:

• Lorazepam
• Midazolam
• Diazepam

For refractory toxin-induced seizures consider:

• Phenobarbital
• Propofol in an intubated patient

Also aggressively correct:

• Hypoxia
• Hypoglycemia
• Electrolyte abnormalities

Hypotension

First address:

• Hypoxia
• Bradycardia
• Cholinergic excess

Give appropriate isotonic crystalloid if the patient is fluid responsive.

If shock persists despite atropine and appropriate volume:

Norepinephrine is generally an appropriate vasopressor.

The older preference for:

• Trendelenburg positioning
• Dopamine as first-choice pressor

is not part of contemporary shock management.

Bronchospasm

The most important treatment is:

Adequate atropinization

because the underlying process is cholinergic.

Additional inhaled bronchodilator therapy may be used when clinically helpful, but bronchodilators do not replace atropine.

Mechanical Ventilation

Mechanical ventilation may be needed despite atropine if there is:

• Neuromuscular weakness
• Central respiratory depression
• Aspiration
• Severe hypoxemia

Continue ventilatory assessment after lung secretions improve.

Enhanced Elimination

There is no established role for:

• Hemodialysis
• Hemoperfusion
• Urinary alkalinization

for routine removal of carbamate insecticides.

Treatment relies on:

• Decontamination
• Airway/ventilatory support
• Atropine
• Supportive care

Intermediate and Delayed Syndromes

Carbamate poisoning is generally shorter-lived than organophosphate poisoning.

Because there is no aging of the carbamate-AChE bond:

• Prolonged cholinergic toxicity is uncommon
• Classic delayed organophosphate neuropathy is not expected

An intermediate syndrome with persistent muscle weakness has occasionally been reported, but it is substantially less characteristic than with organophosphate poisoning.

Monitoring

Symptomatic patients require:

• Continuous ECG
• Continuous pulse oximetry
• Frequent respiratory assessment
• Frequent neurologic assessment

Specifically reassess:

• Bronchial secretions
• Bronchospasm
• Muscle strength
• Ability to ventilate
• Blood pressure

Capnography or blood gases can be useful in significant respiratory compromise.

Admission

ICU

ICU-level care is appropriate for:

• Respiratory distress/failure
• Significant bronchorrhea
• Severe muscle weakness
• Need for intubation
• Repeated/high-dose atropine requirements
• Atropine infusion
• Seizures
• Coma
• Hemodynamic instability

Monitored Admission

Patients requiring atropine should generally be admitted to a monitored setting for continued respiratory assessment.

Moderate poisoning may warrant approximately 24 hours of observation.

Disposition

The older fixed rule of:

“Asymptomatic = discharge after 6 hours”

should not be applied rigidly to every carbamate exposure.

Disposition should consider:

• Specific agent
• Formulation
• Dose
• Route
• Dermal decontamination
• Symptom-free interval
• Coingestants
• Reliability of observation at home

Because carbamate toxicity usually develops rapidly, an adequately observed patient with:

• No symptoms
• Normal vital signs
• No respiratory abnormalities
• Complete decontamination

can often be discharged after an appropriate observation period.

Patients with mild symptoms who never require atropine may also be discharged once completely asymptomatic after observation.

Occupational Exposure

Carbaryl

Current NIOSH Pocket Guide values are:

NIOSH REL: 5 mg/m³ TWA

OSHA PEL: 5 mg/m³ TWA

NIOSH IDLH: 100 mg/m³

Carbofuran

Current NIOSH listing:

NIOSH REL: 0.1 mg/m³ TWA

and:

No specific OSHA PEL listed

Occupational limits are agent specific; they should not be generalized across the entire carbamate class.

Return to Work

The older recommendation that every exposed worker must reach exactly 75% of a personal RBC cholinesterase baseline before returning to all pesticide handling is too simplistic for acute carbamate poisoning.

Return-to-work decisions should consider:

• Full clinical recovery
• Elimination of ongoing exposure
• Workplace investigation
• PPE and engineering controls
• Occupational-health assessment
• Cholinesterase monitoring protocol when applicable

Because carbamate inhibition reverses quickly, a delayed cholinesterase measurement may no longer accurately reflect the acute exposure.

Pregnancy

The old FDA pregnancy letter categories are obsolete.

Significant maternal carbamate poisoning can threaten both mother and fetus through:

• Hypoxemia
• Respiratory failure
• Hypotension
• Severe cholinergic toxicity

Life-saving therapy should not be withheld because of pregnancy.

In particular:

Atropine remains indicated when clinically required.

Maternal stabilization is the priority, with obstetric/fetal assessment according to gestation and poisoning severity.

Prognosis

Compared with organophosphate poisoning, isolated carbamate poisoning generally has:

• Faster spontaneous enzyme recovery
• Shorter duration
• Lower risk of prolonged neurologic syndromes

Most patients recover within approximately:

24 hours

although severe cases can persist for 24–48 hours and may require mechanical ventilation.

Death usually results from:

• Delayed airway management
• Respiratory failure
• Severe aspiration
• Massive exposure
• Severe CNS depression

Important Pitfalls

1. Calling carbamates “low toxicity”

Some carbamate insecticides can cause:

Rapid respiratory failure and death.

Aldicarb and carbofuran are particularly important examples.

2. Waiting for cholinesterase results

Carbamate inhibition is reversible, so cholinesterase results may normalize rapidly or become misleading.

Treat the patient, not the laboratory value.

3. Using pupils as the atropine endpoint

Persistent miosis is not a reason by itself to continue escalating atropine.

The important endpoint is:

Drying of bronchial secretions + improved bronchospasm + adequate perfusion

4. Stopping atropine because the patient is tachycardic

Tachycardia may reflect:

• Nicotinic stimulation
• Hypoxemia
• Physiologic stress

If the chest remains wet and the patient is bronchospastic:

More atropine may still be needed.

5. Assuming atropine corrects muscle weakness

Atropine treats muscarinic toxicity.

It does not reverse nicotinic:

• Fasciculations
• Weakness
• Respiratory paralysis

Continue to monitor ventilation carefully.

6. Giving pralidoxime automatically to every confirmed carbamate patient

For a known isolated carbamate poisoning, oximes are generally unnecessary.

They are particularly controversial in carbaryl exposure.

7. Withholding pralidoxime when the pesticide is unknown

If severe cholinergic poisoning could represent an organophosphate:

Treat empirically as an organophosphate until the exposure is clarified.

8. Failing to protect healthcare workers

Pesticides remaining on:

• Clothing
• Skin
• Hair
• Vomitus

can cause secondary contamination.

PPE and decontamination should occur early.

9. Using succinylcholine for intubation

Cholinesterase inhibition may prolong its action dramatically.

Rocuronium or another nondepolarizing agent is generally preferable.

10. Treating the heart rate instead of the lungs

The most immediate danger is usually:

Bronchorrhea + bronchospasm + respiratory failure

not the exact pulse rate.

High-Yield Toxicology Pearls

Carbamate insecticides = reversible cholinesterase inhibitors

Think:

Wet + pinpoint + twitching + weak

Classic severe syndrome:

Bronchorrhea + miosis + vomiting/diarrhea + fasciculations → weakness → respiratory failure

Key points:

• Mechanism: reversible acetylcholinesterase inhibition
• Unlike organophosphates, carbamates do not undergo aging
• Clinical effects are usually shorter, often resolving within 24–48 h
• Muscarinic effects:
• 
  
• Bronchorrhea
• Bronchospasm
• Salivation
• Lacrimation
• Vomiting/diarrhea
• Miosis
• Bradycardia
• Nicotinic effects:
• 
  
• Fasciculations
• Muscle weakness
• Respiratory paralysis
• Tachycardia/hypertension may occur
• CNS effects:
• 
  
• Confusion
• Seizures
• Coma
• Main cause of death: respiratory failure
• Diagnosis is primarily clinical
• Cholinesterase levels may be misleading because carbamate inhibition reverses rapidly
• Do not delay treatment for cholinesterase testing
• Remove contaminated clothing and wash skin/hair thoroughly
• Protect healthcare workers from secondary contamination
• Avoid induced vomiting
• GI decontamination has only a limited, selected role
• Main antidote: ATROPINE
• Adult atropine start: approximately 1–3 mg IV
• Pediatric atropine: approximately 0.05 mg/kg IV
• If inadequate response: double the atropine dose every ~5 min
• Atropine endpoint:
• 
  
• Drying bronchial secretions
• Reduced bronchospasm
• Adequate perfusion
• Do not titrate atropine to pupil size
• Tachycardia alone does not contraindicate atropine
• Maintenance atropine infusion: approximately 10–20% of total loading dose per hour
• Atropine does not reverse nicotinic muscle paralysis
• Avoid succinylcholine because paralysis may be prolonged
• Pralidoxime usually not needed in confirmed isolated carbamate poisoning
• Avoid routine pralidoxime especially in known carbaryl poisoning
• If the pesticide is unknown and organophosphate exposure remains possible → give atropine and consider pralidoxime
• Seizures → benzodiazepines
• Severe toxicity → early airway control and ICU care